Sickle cell Anaemia: The Need for Increased Drug Development in Africa

[1] Okoh MP, Alli LA, Tolvanen ME, Nwegbu MM. Herbal Drug use in Sickle Cell Disease Management; Trends and Perspectives in Sub-Saharan Africa - A Systematic Review. Curr. Drug Discov. Technol. 2018;16(4):372–385.10.2174/1570163815666181002101611 Search in Google Scholar

[2] Makani J, Ofori-Acquah SF, Nnodu O, Wonkam A, Ohene-Frempong K. Sickle cell disease: new opportunities and challenges in Africa. Sci. World J. 2013;2013:1-16.10.1155/2013/193252 Search in Google Scholar

[3] Gardner RV. Sickle cell disease: Advances in treatment. Ochsner J. 2018;18(4):377-389.10.31486/toj.18.0076 Search in Google Scholar

[4] Steinberg MH. Review: Sickle cell disease: Present and future treatment. Am. J. Med. Sci. 1996;312(4):166-174.10.1016/S0002-9629(15)41800-2 Search in Google Scholar

[5] Shah N, Bhor M, Xie L, Paulose J, Yuce H. Sickle cell disease complications: Prevalence and resource utilization. BioRxiv. 2019:2-13.10.1101/577189 Search in Google Scholar

[6] Chakravorty S, Williams TN. Sickle cell disease: A neglected chronic disease of increasing global health importance. Arch. Dis. Child. 2015;100(1):48-53.10.1136/archdischild-2013-303773 Search in Google Scholar

[7] Booth C, Inusa B, Obaro SK. Infection in sickle cell disease: A review. Int. J. Infect. Dis. 2010;14(1).10.1016/j.ijid.2009.03.010 Search in Google Scholar

[8] Mansour AK, Yahia S, El-ashry R, Alwakeel A, Darwish A, Alrjjal K. Sickle cell disease. Sickle Cell Disease (SCD). 2016;2015:p 1-1410.5772/61162 Search in Google Scholar

[9] Diallo D, Tchernia G. Sickle cell disease in Africa. Curr. Opin. Hematol. 2002;9(2):111-116.10.1097/00062752-200203000-00005 Search in Google Scholar

[10] Piel FB. Global epidemiology of Sickle haemoglobin in neonates: A contemporary geostatistical mode; -based map and population estimates. Lancet. 2013;381(9861):142–151.10.1016/S0140-6736(12)61229-X Search in Google Scholar

[11] Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN. Sickle cell disease in Africa: A neglected cause of early childhood mortality. Am. J. Prev. Med. 2011;41(6):S398-S405.10.1016/j.amepre.2011.09.013370812622099364 Search in Google Scholar

[12] McAuley CF. High mortality from Plasmodium falciparum malaria in children living with sickle cell anaemia on the coast of Kenya. Blood. 2010;116(10):1663–1668.10.1182/blood-2010-01-265249307342320530796 Search in Google Scholar

[13] Ndila C. Verbal autopsy as a tool for identifying children dying of sickle cell disease: A validation study conducted in Kilifi district, Kenya. BMC Med. 2014;12(1):1–9.10.1186/1741-7015-12-65402233024755265 Search in Google Scholar

[14] Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA. 2003;289(13):1645-51.10.1001/jama.289.13.164512672732 Search in Google Scholar

[15] Lanzkron S, Patrick C, Haywood C. Mortality rates and age at death from sickle cell disease: U.S., 1979-2005. Public Health Rep. 2013;128(2):110–116.10.1177/003335491312800206356086823450875 Search in Google Scholar

[16] U.S. Department of Health and Human Services. Evidence based management of sickle cell disease. 2014:77 [Online]. Available: https://www.nhlbi.nih.gov/sites/default/files/media/docs/sickle-cell-diseasereport020816_0.pdf. Search in Google Scholar

[17] Tshilolo L, Tomlinson G, Williams TN, Santos B, Olupot-Olupot P, Lane A, Aygun B, Stuber SE, Latham TS, McGann PT, Ware RE; REACH Investigators. Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa. N Engl J Med. 2019;380(2):121-131.10.1056/NEJMoa1813598645457530501550 Search in Google Scholar

[18] Basu P, Jia H. Trading on traditional medicines. Nat. Biotechnol. 2004;22(3):263–265.10.1038/nbt0304-263 Search in Google Scholar

[19] Akinsulie AO, Temiye EO, Akanmu AS, Lesi FE, Whyte CO. Clinical evaluation of extract of Cajanu cajan (Ciklavit®) in sickle cell anaemia. J. Trop. Pediatr. 2005;51(4):200–205.10.1093/tropej/fmh097 Search in Google Scholar

[20] Ameh SJ, Obodozie OO, Inyang US, Abubakar MS, Garba M. Climbing black pepper (Piper guineense) seeds as anti-sickling remedy, in Nuts and Seeds in Health and Disease Prevention. V.R Preedy, R. R. Watson and V.B.Patel, Eds. Academic Press, London, UK. 2011;1:333-343.10.1016/B978-0-12-375688-6.10040-4 Search in Google Scholar

[21] Ameh JS, Obodozie OO, Babalola PC, Gamaniel KS. Medical herbalism and herbal clinical research—a global perspective. Brit J Pharm Res. 2011;1(4):99–123.10.9734/BJPR/2011/403 Search in Google Scholar

[22] Ameh SJ, Obodozie OO, Chindo BA, Babalola PC, Gamaniel KS. Herbal clinical trials—historical development and application in the 21st Century. Pharmacologia, 2012;3:121–131.10.5567/pharmacologia.2012.121.131 Search in Google Scholar

[23] Perampaladas K, Masum H, Kapoor A, Shah R, Daar AS, Singer PA. The road to commercialization in Africa: lessons from developing the sickle-cell drug Niprisan. BMC Int Health Hum Rights. 2010;10(1):1-7.10.1186/1472-698X-10-S1-S11300160821144071 Search in Google Scholar

[24] Humphries C. Drug Development: A complicated path. Nature. 2014;515:S4- S5.10.1038/515S4a25390140 Search in Google Scholar

[25] Makani J, Ofori-Acquah SF, Nnodu A, Wonkam A, Ohene-Frempong K. Sickle Cell Disease: New Opportunities and Challenges in Africa. Sci Word J. 2013;2013(193252).10.1155/2013/193252398889225143960 Search in Google Scholar

[26] Sigonda M, Miot J, Naidoo S, Dodoo A, Kaale E. Medicines Regulation in Africa: Current State and Opportunities. Pharm Med. 2017;31:383-97.10.1007/s40290-017-0210-x569112229200865 Search in Google Scholar

[27] Puppalwar G, Mourya M, Kadhe G, Mane A. Conducting clinical trials in emerging markets of sub-Saharan Africa: Review of guidelines and resources for foreign sponsors. Open Access J Clin Trials. 2015;7:23-34.10.2147/OAJCT.S77316 Search in Google Scholar

[28] Abere TA, Okoye CJ, Agoreyo FO. Antisickling and toxi- cological evaluation of the leaves of Scoparia dulcis Linn (Scro- phulariaceae). BMC Complement Altern Med. 2015;15:414.10.1186/s12906-015-0928-5465727226597857 Search in Google Scholar